Company: RDPTF
Filing Date: 2025-09-18
Form Type: 20-F
Source: 0001213900-25-088699
Chunk: 110

Company: Radiopharm Theranostics Ltd
Filing Date: 2025-09-18
Form: 20-F
Item: Item 6
Chunk 110
---
───────────────────────────────────────────────────────
  **       All options issued under ESOP have vesting conditions that are based on the achievement of service milestones, which are achieved if the holder remains with the company until the date is reached.  
  (1)      Noel Donnelly was appointed as Director on October 1, 2024.                                                                                                                                          

(End of the Remuneration
Report forAustralian Disclosure Requirements)

Other Australian Disclosure Requirements

Shares under options and performance rights

(a) Unissued ordinary shares

Unissued ordinary shares of Radiopharm Theranostics Limited under options
at the date of this report are as follows:

  Date options issued        Expiry date      Issue price                              
                                                                                       
                                              of shares                                
                                              ($)                                      
  2019-07-16 (warrants)      2024-07-16       USD               0.125         116,120  
  2020-07-24 (warrants)      2025-07-21       USD              0.5859       2,560,000  
 ───────────────────────────────────────────────────────────────────────────────────────
  2020-10-29                 2024-11-13                          0.12       7,900,000  
  2021-10-26                 2025-10-26                          0.25         500,000  
  2022-06-27                 2026-06-27                          0.12       1,430,000  
  2023-11-21                 2027-11-21                          0.25       1,000,000  
  2024-06-19                 2028-06-19                          0.13       1,000,000  
  Total                                                                    14,506,120  

(b) Shares issued on the exercise of options

No ordinary shares of Radiopharm Theranostics Limited were issued during
the year ended 30 June 2025 on the exercise of options granted.

Insurance of officers and indemnities

(a) Insurance of officers

During the financial year, Radiopharm Theranostics Limited has paid
a premium in respect of a contract to insure the directors and officers of the group against a liability to the extent permitted by Corporations
Act 2001.

(b) Indemnity of auditors

The group has not otherwise, during